Navigation Links
Elsevier introduces 'Aesthetic Plastic Surgery'
Date:10/27/2009

Philadelphia, PA, 27 October 2009 - Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announced the release of a brand-new single volume comprehensive book on contemporary aesthetic plastic surgery.

Drs. Aston, Steinbrech and Walden, renowned plastic surgeons in New York share their trade secrets of aesthetic plastic surgery in a procedure-oriented and illustrated reference, "Aesthetic Plastic Surgery". Along with leading international contributors, they present today's most comprehensive in-depth view of the current state of aesthetic plastic surgery.

"We've showcased the most successful aesthetic surgery procedures that we, as well as our contributing authors, use on an almost daily basis," said Dr. Sherrell Aston, MD. "The information will be useful to you regardless of whether you are an experienced surgeon or just beginning your practice."

This reference brings to the table the masterful expertise needed to achieve the desired outcomes for every cosmetic surgery procedure, including the MACS lift, endoscopic mid- and lower face rejuvenation, lid/cheek blending along the tear trough, cohesive gel breast augmentation, lipoabdominoplasty, injectables such as Botox, Radiesse, Restylane, Sculptra, nonsurgical ultrasonic fat reduction, suture suspension threadlifts, and many more.

"This comprehensive text is procedurally-oriented, and lavishly illustrated and provides stepwise guidance to techniques," commented Sue Hodgson, Publishing Director for Global Medicine at Elsevier. "All of the major contemporary procedures in aesthetic plastic surgery are covered and described by the experts in the field. It is a resource no surgeon who performs aesthetic procedures can afford to be without."

The three editors are:

  • Sherrell Aston, MD, FACS is one of the world's preeminent plastic surgeons and educators. He is a past president of the American Society for Aesthetic Plastic Surgery, and Chairman of the Department of Plastic Surgery at the prestigious Manhattan Eye, Ear and Throat Hospital, New York. He also serves as a Professor of Plastic Surgery at the New York University School of Medicine.
  • Douglas Steinbrech, MD, FACS is Clinical Assistant Professor of Plastic Surgery at the New York University School of Medicine and an Attending Surgeon at Manhattan, Eye, Ear and Throat Hospital, New York.
  • Jennifer L. Walden, MD, FACS is Attending Surgeon, Program Director in Plastic Surgery at Manhattan Eye, Ear and Throat Hospital, New York. She is also a Clinical Instructor of Plastic Surgery at New York University School of Medicine.

"Aesthetic Plastic Surgery", (found at www.us.elsevierhealth.com) features a bonus DVD and comes with access to the full text online, downloadable images and procedural videos at Elsevier's Expert Consult web site (www.expertconsult.com).


'/>"/>

Contact: Tom Reller
t.reller@elsevier.com
215-239-3508
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier launches new journal: Stem Cell Research
2. Elsevier announces new journal on inflammatory bowel diseases
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
5. Elsevier journals participate widely in global theme issue on poverty and human development
6. ScienceDirect to host French-language journals from Elsevier Masson
7. Elseviers "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights
8. Elseviers WiserWiki allows physicians to update evidence-based medical information
9. Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars
10. Elsevier Foundation announces grants for innovative libraries and new scholars
11. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: